These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1355969)

  • 1. Neurotransmitters are important, but so is metabolism. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Gur RE; Gur RC
    Neuropsychopharmacology; 1992 Aug; 7(1):63-5; discussion 73-5. PubMed ID: 1355969
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Buchsbaum MS
    Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970
    [No Abstract]   [Full Text] [Related]  

  • 3. PET scanning in schizophrenia, a critical evaluation. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Murphy D; Rapoport SI
    Neuropsychopharmacology; 1992 Aug; 7(1):59-61; discussion 73-5. PubMed ID: 1524656
    [No Abstract]   [Full Text] [Related]  

  • 4. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P
    Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract]   [Full Text] [Related]  

  • 6. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of anti-psychotic agents on brain glucose metabolism and regional cerebral circulation in patients with schizophrenia-- study by functional brain imaging of SPECT and PET].
    Jibiki I
    Seishin Shinkeigaku Zasshi; 2002; 104(2):144-51. PubMed ID: 11985069
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurochemical imaging in schizophrenia.
    Urban N; Abi-Dargham A
    Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS; Koppel J; Goldberg S
    Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography scans in schizophrenia.
    Pal H; Saxena S
    Natl Med J India; 1994; 7(2):74. PubMed ID: 8019402
    [No Abstract]   [Full Text] [Related]  

  • 11. Searching for the neuropathology of schizophrenia: neuroimaging strategies and findings.
    Lieberman JA
    Am J Psychiatry; 1999 Aug; 156(8):1133-6. PubMed ID: 10450250
    [No Abstract]   [Full Text] [Related]  

  • 12. [Positron emission tomography. A new measurement method for imaging of regional and biochemical parameters].
    Bolwig TG; Haunsø S; Hove JD; Hesse B; Højgaard L; Jensen M; Paulson OB; Svendsen JH; Sørensen SS
    Ugeskr Laeger; 1994 Oct; 156(43):6341-7. PubMed ID: 7810006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
    Fredrickson P; Richelson E
    J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial low frequency pattern analysis in positron emission tomography: a study between normals and schizophrenics.
    Levy AV; Gomez-Mont F; Volkow ND; Corona JF; Brodie JD; Cancro R
    J Nucl Med; 1992 Feb; 33(2):287-95. PubMed ID: 1732457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic research strategies for imaging neurotransmitter systems.
    Snyder SH
    NIDA Res Monogr; 1986; 74():6-14. PubMed ID: 2892136
    [No Abstract]   [Full Text] [Related]  

  • 16. Schizophrenia research. Neurobiology/imaging.
    J Psychiatry Neurosci; 1994 Nov; 19(5 Suppl 1):39-42. PubMed ID: 7803380
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET scanning and schizophrenia--what progress?
    Liddle PF
    Psychol Med; 1992 Aug; 22(3):557-60. PubMed ID: 1410081
    [No Abstract]   [Full Text] [Related]  

  • 19. The spectral signature method for the analysis of PET brain images.
    Levy AV; Laska E; Brodie JD; Volkow ND; Wolf AP
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A103-13. PubMed ID: 1997478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.